Lv3
250 积分 2024-10-31 加入
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
25天前
已完结
Tissue distribution of lymphocytes and plasma cells and the role of the gut
27天前
已完结
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies
1个月前
已完结
Structure-based design and disulfide stapling of interfacial cyclic peptidic inhibitors from thymic stromal lymphopoietin (TSLP) receptor to competitively target TSLP
1个月前
已完结
The renaissance of oral tolerance: merging tradition and new insights
1个月前
已完结
Synthesis and biological evaluation of peptide-derived TSLP inhibitors
1个月前
已完结
Synthesis and biological evaluation of peptide-derived TSLP inhibitors
2个月前
已完结
The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug
2个月前
已完结
Overcoming Challenges in the Metabolism of Peptide Therapeutics: Strategies and Case Studies for Clinical Success
2个月前
已完结
Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
2个月前
已完结
皖公网安备34019202002308
